Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 14,046.66 802.58 196.25 -222.32 30.62 0.00 17.5254 -0.40 -1.0105 -23.1639 -0.09 -0.08 7.7016 - -
Maximum - - - - - - 475,026.00 65,349.00 25,407.00 99,050.00 5,305.00 0.01 1,336.3467 6.70 3.0051 85.3485 0.38 8.35 61.5621 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -101.7758 -1,444.7800 -1.56 -12.64 0.0007 - -
Moderna, Inc. MRNA 46.83 -3.45 -6.86% 13,476 vs. 5,129 18,001.00 167.00 -1,175.00 -1,185.00 12,431.00 -3.0800 -8.5828 0.0000 0.2096 -7.0359 -0.0917 -0.0702 3.7508 384.00
CureVac N.V. CVAC 2.84 0.01 0.35% 715 vs. 439 637.00 12.00 -70.00 -101.00 -1,636.00 -0.3100 -2.2038 0.0000 -2.3694 -5.7022 -0.1579 -0.1022 2.0371 224.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for 22UA.F and its peers to uncover potential buy and sell opportunities.